Pricing Log in Create free account

AEON Biopharma, Inc. (AEON) vs CASI Pharmaceuticals Inc. (CASIF)

AEON Biopharma, Inc. and CASI Pharmaceuticals Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. is the larger, with a market value of $12.4M against $9.4M — 1.3× the size. AEON Biopharma, Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, AEON Biopharma, Inc. leads on 7 and CASI Pharmaceuticals Inc. on 4.

Valuation

Metric AEON CASIF Biotechnology median
P/E n/m n/m 10.26
P/S n/m 0.09 9.18
P/B n/m n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 1.79 8.98
Earnings yield (2,762.50%) (2,701.50%) (34.89%)
Free cash flow yield (168.78%) (3,801.00%) (24.52%)

Profitability

Metric AEON CASIF Biotechnology median
Gross margin — 48.65% 65.16%
Operating margin 0.00% (206.87%) 0.00%
Net margin 0.00% (232.03%) 0.00%
Free cash flow margin 0.00% (340.20%) 0.00%
Return on equity 350.00% 0.00% (50.12%)
Return on assets (621.70%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON CASIF Biotechnology median
Revenue growth (TTM) — (27.42%) 6.26%
EPS growth (last fiscal year) (105.42%) (1.17%) 29.88%
Revenue growth, 5-year CAGR — 6.47% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON CASIF Biotechnology median
Debt to equity 0.00 (0.34) 0.00
Current ratio 0.54 0.15 4.89
Net debt to EBITDA (2.48) (0.43) 1.01

Dividend

Metric AEON CASIF Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AEON CASIF Biotechnology median
Market cap 9.35m 12.39m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack